Eli Lilly and Company LLY

Company Overview

Eli Lilly and Company is a global pharmaceutical company focused on the discovery, development, manufacturing, and commercialization of prescription medicines. The company operates primarily within the biopharmaceutical industry, with a strong emphasis on chronic and complex diseases. Its core therapeutic areas include diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular disease, which together represent the majority of its revenue base.

Founded in 1876, Eli Lilly has evolved from a small drug manufacturing enterprise into one of the world’s largest research-driven pharmaceutical companies. Its growth has been shaped by sustained investment in internal research and development, a vertically integrated manufacturing model, and a strategy centered on innovative biologics and specialty medicines. In recent years, the company has achieved a dominant market position in metabolic diseases, particularly diabetes and obesity, driven by differentiated injectable therapies and expanding global demand.